Oculus announces encouraging data from Phase II foot ulcer trial
In the clinically evaluable population of the study, the clinical success rate at visit 3 (End of Therapy) for Microcyn-alone-treated patients was 77.8% compared to 61.1% for the

In the clinically evaluable population of the study, the clinical success rate at visit 3 (End of Therapy) for Microcyn-alone-treated patients was 77.8% compared to 61.1% for the

The test simultaneously detects and identifies cystic fibrosis (CF) mutations in patient DNA samples. The InPlex CF Molecular Test delivers the accuracy of Third Wave’s Invader chemistry in

The trial is being conducted at 30 allergy specialty centers across the US and will enroll approximately 458 patients. Participants must be ages 18-50 and have a history

Anadis and Garden State Nutritionals (GSN) plan to introduce in the coming months and years a range of products, all based on Anadis’s proprietary and all-natural milk-derived (colostrum)

The study included a four-week, multicenter, double-blind treatment period during which 433 children were randomized to receive either Nasacort AQ 110 micrograms or placebo as one spray per

Genentech has stated that it plans to initiate three Phase II clinical trials of GDC-0449 in 2008, which include a trial in metastatic colorectal cancer during the first

The randomized, double-blind, placebo-controlled, Phase II study is being conducted at 20 centers throughout the US. The objective of this study is to examine the safety and efficacy

Irinotecan hydrochloride Injection, the generic equivalent to Pfizer’s Camptosar, is used to treat patients with metastatic carcinoma of the colon or rectum. Doug Boothe, executive vice president of

In this study, 115 short ragweed pollen-sensitive subjects, ages 19-50 with a history of allergic rhinitis, were randomized into three treatment arms. Efficacy was evaluated using reduction in

This was an observational study evaluating the rates of asthma-related hospitalizations and emergency department (ED) visits in children four to 11 years of age with persistent asthma. To